Polynovo Ltd
ASX:PNV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Polynovo Ltd
Accrued Liabilities
Polynovo Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Polynovo Ltd
ASX:PNV
|
Accrued Liabilities
AU$3m
|
CAGR 3-Years
32%
|
CAGR 5-Years
37%
|
CAGR 10-Years
45%
|
|
|
Nanosonics Ltd
ASX:NAN
|
Accrued Liabilities
AU$7.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
SDI Ltd
ASX:SDI
|
Accrued Liabilities
AU$3.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Anteris Technologies Ltd
ASX:AVR
|
Accrued Liabilities
AU$9.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
|
|
Ansell Ltd
ASX:ANN
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Lumos Diagnostics Holdings Ltd
ASX:LDX
|
Accrued Liabilities
$1.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Polynovo Ltd
Glance View
Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.
See Also
What is Polynovo Ltd's Accrued Liabilities?
Accrued Liabilities
3m
AUD
Based on the financial report for Dec 31, 2025, Polynovo Ltd's Accrued Liabilities amounts to 3m AUD.
What is Polynovo Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
45%
Over the last year, the Accrued Liabilities growth was 9%. The average annual Accrued Liabilities growth rates for Polynovo Ltd have been 32% over the past three years , 37% over the past five years , and 45% over the past ten years .
